TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
planning
Official procurement procedure

Supply of Plasmids and Synthetic DNA for Viral Vector Manufacture

Clinical products
South West (UKK11)
Published value
£7,200,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Supply of Plasmids and Synthetic DNA for Viral Vector Manufacture". Published status: planning. Published value: £7,200,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Blood and TransplantScope & CategoriesNot publishedSubmission Window
planning
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£7,200,000
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.9Bids / Report
65% of reports have one bid
Supplier ConcentrationHigh Concentration
Carmelcrest LtdTop vendor: 66.6% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 65 active published awards; 20 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
Carmelcrest Ltd1 win£1,098,370
Jobtrain Limited2 wins£186,954
CRYOPDP1 win£108,014
Arctic Shores Limited1 win£93,000
Osteopaths For Industry Limited1 win£60,000
Procedure terms
Contracting AuthorityNHS Blood and Transplant
Procedure methodNot published
Procurement categoryNot published
Statusplanning
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published13 Aug 2025, 08:21 BST
Last source update13 Aug 2025, 08:21 BST
Recurring procurementNot published
ClassificationClinical products
Delivery area
South West (UKK11)
OCIDocds-h6vhtk-0586a2
What is being bought
As part of a preliminary market engagement exercise, NHS Blood & Transplant (NHSBT) are seeking to engage with suppliers of nucleic acids including plasmid DNA; synthetically produced DNA and/or enzymatically produced DNA. The intended use of the nucleic acids by NHSBT includes: a) the GMP grade production of gene therapy vectors such as lentiviral, adeno-associated viral vectors and novel gene therapy vectors, for clinical trials and commercial production where applicable; b) gene therapy vectors suitable for pre-clinical studies, such as toxicology and biodistribution studies and gene therapy vectors suitable for R&D purposes.
What changed
From the official release history
  1. Published value updated to £7,200,000
    13 Aug 2025, 08:21 BST
  2. Status changed to planning
    13 Aug 2025, 08:21 BST
  3. Official notice release published
    13 Aug 2025, 08:21 BST
  4. Buyer information updated
    13 Aug 2025, 08:21 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    planning
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Pipeline notice
    13 Aug 2025, 08:21 BST
  2. Procedure published
    13 Aug 2025, 08:21 BST
  3. engagement
    12 Sept 2025, 23:59 BST · scheduled
    NHSBT conducted initial market engagement for ' Supply of Viral Vector Plasmids', via issue of a PIN under the Procurement Contract Regulations (Notice Identifier: 2024/S 000-029545). NHSBT have since updated the requirement to include synthetically produced DNA and/or enzymatically produced DNA. Therefore NHSBT are looking to engage further with suppliers who may have been missed from the initial market engagement, due to synthetic plasmids not being included. If you are interested in taking part in the market engagement, please contact james.marshall2@nhsbt.nhs.uk by no later than 12:00 hrs (GMT) on 12/09/2025. Market engagement is likely to take place via video calls in September 2025. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS Blood and Transplant

Contracting authority GB-PPON-PDBY-6395-VWBP
View buyer profile
Documents (1)
Official links; attachments are not copied
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleNot published